Teams of scientists from around the world envisage new solutions and methods for treating and preventing different kinds of allergic diseases, thanks to our gut microbiota and its preventive role.
Beyond genetics and lifestyle, the gut microbiome is now emerging as an important factor in cancer progression and treatment response. This raises an important question: could understanding and targeting this ecosystem transform the way we treat cancer?
The fifth edition of IBS Days delved into the latest developments in IBS research and clinical management. This article aims to explore causes that can be misdiagnosed as IBS and non-pharmacological strategies targeting gut barrier and gut microbiome dysfunction.
Bifidobacteria are increasingly studied as a marker of gut health across a lifetime. In this interview, microbiome researcher Sudarshan Shetty explains what shapes them, how they change with age, and what diet can do.
